cb-logo-web-retina

Joseph

Age: 73
Caucasian
Male
Histology: LGD

Prague Classification:

C3M4

Other Comments:

Prior Patient History of HGD, Now LGD Post-Ablation, Dysphagia

GUIDELINES WOULD SUGGEST:

Every 12 months

Treatment Comparison

Instructions: To begin your treatment comparison using the TissueCypher® Barrett's Esophagus Assay, please click continue. Your treatment choices will be recorded before and after reviewing the TissueCypher® report. Your treatment choices and the results from all participants to date will be displayed on a summary screen when completed. Let's begin!
 
Provide your answer to the following treatment questions based on the initial patient data provided, then click Continue:
Based on the additional information provided by the TissueCypher® Report, provide your answer to the following treatment questions, then click Continue:
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode
PATIENT RESULTS: TISSUECYPHER® RISK SCORE AND RISK CLASS

COMPLETE TISSUECYPHER® REPORT
Fullscreen Mode